Article -> Article Details
| Title | Gene Therapy Market: Industry Analysis, Opportunity and Forecast to 2030 |
|---|---|
| Category | Fitness Health --> Health Articles |
| Meta Keywords | Gene Therapy Market: Industry |
| Owner | Vaibhav |
| Description | |
|
Durable Medical Equipment Industry
size is expected to rise at a CAGR of
23.30%, with a value of USD 524 million during the estimated the forecasting
year of 2022-2030. The research report profiles the global gene therapy market in great
detail and provides readers with a comprehensive overview of the market. The
market’s historical growth trajectory, present conditions, and future growth
prospects are studied in the report. The report provides a comprehensive
overview of the market’s historical growth trajectory by detailing the
historical stats regarding the market. Future projections are based on the
detailed historical stats offered in the report. Based on this platform, future
projections for the gene therapy market’s growth trajectory over the forecast
period are provided in the report. The report also profiles the leading players
in the global gene therapy market and gives readers a comprehensive analysis of
the leading players in the global gene therapy market. The report also profiles
the major drivers and restraints affecting the global gene therapy market. The
factors making the market tick and those holding the market back are studied in
detail in the report. The impact of the COVID-19 pandemic on the gene therapy
market is also assessed in the report. Gene therapy involves therapies that target the genetic root cause of a
disease and eradicate the disease at this base level. The system is focused on
the use of introduced nucleic acids as an alternative to drugs. The use of
edited genes can eradicate the need for drugs altogether, as, in future,
scientists will be able to cure diseases by simply introducing a novel genetic
component into the genome of the patient. The introduction of the CRISPR gene
editing tool is a major driver for the global gene therapy market, as this has
made gene editing much easier than before. The growing prevalence of cancer has driven the demand for effective
gene therapies for the same. This is likely to be a major driver for the global
gene therapy market over the forecast period. The increasing prevalence of
cancer has been a major strain on healthcare resources around the world. As a
result, many governments as well as private players have invested significantly
in finding a treatment for cancer. This is likely to remain a major driver for
the global gene therapy market over the forecast period. Major Key
Players: Some of the Market Major
Player are Amgen, Inc. (US), Novartis AG (Switzerland), Spark
Therapeutics, Inc. (US), Gilead Sciences, Inc. (US), uniQure N.V.
(Netherlands), Orchard Therapeutics plc (UK), Celgene Corporation (US), Bristol-Myers
Squibb Company (US), Thermo Fisher Scientific Inc. (US), CEVEC (Germany), and
Lonza (Switzerland). Segment Analysis The global Gene Therapy Market
Research based on product, indication, and end
user. The market, based on product, has been divided into
kymriah, luxturna, yescarta, zolgensma, strimvelis, zynteglo, imlygic, and
others. The global gene therapy market has on the basis of
indication is segmented, into oncology, genetic diseases/ disorders, and
others. The oncology segment is expected to hold the largest market share
and to be the fastest-growing segment due to high prevalence of cancer and
robust pipeline for cancer gene therapy. The end-user segments of the market are
hospitals & clinics, specialty treatment centers, and others. The
hospitals & clinics segment is expected to hold the largest market share
due to increasing number of hospitals. Also, hospitals are generally the first
treatment choice for diseases. Regional Analysis The global gene therapy market is studied across four major regions:
Asia-Pacific, Europe, the Americas, the Middle East, and Africa. According to the MRFR reports, the American regional gene therapy market
is likely to dominate globally over the review timeframe. The regional market's
growth is driven by the rising per capita medical care consumption and the
expanding pervasiveness of quality treatment. The regional market is further
divided into Latin America and North America. The European regional market will likely register substantial growth
over the review timeframe. The region is further divided into Eastern Europe
and Western Europe. The well-established medical infrastructure is driving the
regional market's growth. The Asia-Pacific region is projected to grow at the highest pace over
the coming years. The bringing issues are driving the regional market's growth
to light about the treatment strategies and growing number of patients. Given the lack of skilled professionals and poor health infrastructure,
the gene therapy market for the Middle East & African region is likely to
record the CAGR over the assessment timeframe. About Market Research
Future At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services. MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients. Our
market research studies by products, services, technologies, applications, end
users, and market players for global, regional, and country level market
segments, enable our clients to see more, know more, and do more, which help to
answer all their most important questions. In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members. Contact us: Market Research Future
(part of Wantstats Research and Media Private Limited), 99 Hudson Street, 5Th Floor, New York, New York 10013 United States of America +1 646 845 9312 | |